List of Tables
Table 1. Global Anti-premature Ejaculation Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-premature Ejaculation Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-premature Ejaculation Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-premature Ejaculation Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-premature Ejaculation Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-premature Ejaculation Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-premature Ejaculation Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-premature Ejaculation Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-premature Ejaculation Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-premature Ejaculation Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-premature Ejaculation Drug, Product Type & Application
Table 12. Global Key Manufacturers of Anti-premature Ejaculation Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-premature Ejaculation Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-premature Ejaculation Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-premature Ejaculation Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-premature Ejaculation Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-premature Ejaculation Drug Sales Market Share by Region (2020-2025)
Table 19. Global Anti-premature Ejaculation Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-premature Ejaculation Drug Sales Market Share by Region (2026-2031)
Table 21. Global Anti-premature Ejaculation Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-premature Ejaculation Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-premature Ejaculation Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-premature Ejaculation Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-premature Ejaculation Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-premature Ejaculation Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-premature Ejaculation Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-premature Ejaculation Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-premature Ejaculation Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-premature Ejaculation Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-premature Ejaculation Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-premature Ejaculation Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-premature Ejaculation Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-premature Ejaculation Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-premature Ejaculation Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-premature Ejaculation Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-premature Ejaculation Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-premature Ejaculation Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-premature Ejaculation Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-premature Ejaculation Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-premature Ejaculation Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-premature Ejaculation Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-premature Ejaculation Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-premature Ejaculation Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-premature Ejaculation Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-premature Ejaculation Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-premature Ejaculation Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-premature Ejaculation Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-premature Ejaculation Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-premature Ejaculation Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-premature Ejaculation Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-premature Ejaculation Drug Sales Market Share by Type (2020-2025)
Table 53. Global Anti-premature Ejaculation Drug Sales Market Share by Type (2026-2031)
Table 54. Global Anti-premature Ejaculation Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-premature Ejaculation Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-premature Ejaculation Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-premature Ejaculation Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-premature Ejaculation Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-premature Ejaculation Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-premature Ejaculation Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-premature Ejaculation Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-premature Ejaculation Drug Sales Market Share by Application (2020-2025)
Table 63. Global Anti-premature Ejaculation Drug Sales Market Share by Application (2026-2031)
Table 64. Global Anti-premature Ejaculation Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-premature Ejaculation Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-premature Ejaculation Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-premature Ejaculation Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-premature Ejaculation Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-premature Ejaculation Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Menarini Group Company Information
Table 71. Menarini Group Description and Business Overview
Table 72. Menarini Group Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Menarini Group Anti-premature Ejaculation Drug Product
Table 74. Menarini Group Recent Developments/Updates
Table 75. Ampio Pharmaceuticals Inc Company Information
Table 76. Ampio Pharmaceuticals Inc Description and Business Overview
Table 77. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product
Table 79. Ampio Pharmaceuticals Inc Recent Developments/Updates
Table 80. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
Table 81. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Description and Business Overview
Table 82. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product
Table 84. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
Table 85. AdvaCare Company Information
Table 86. AdvaCare Description and Business Overview
Table 87. AdvaCare Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AdvaCare Anti-premature Ejaculation Drug Product
Table 89. AdvaCare Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Anti-premature Ejaculation Drug Distributors List
Table 93. Anti-premature Ejaculation Drug Customers List
Table 94. Anti-premature Ejaculation Drug Market Trends
Table 95. Anti-premature Ejaculation Drug Market Drivers
Table 96. Anti-premature Ejaculation Drug Market Challenges
Table 97. Anti-premature Ejaculation Drug Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-premature Ejaculation Drug
Figure 2. Global Anti-premature Ejaculation Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-premature Ejaculation Drug Market Share by Type: 2024 & 2031
Figure 4. Serotonin Reuptake Inhibitors Product Picture
Figure 5. Phosphodiesterase Type 5 Inhibitors Product Picture
Figure 6. Local Anesthetic Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-premature Ejaculation Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-premature Ejaculation Drug Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Retail Pharmacy
Figure 12. Clinic
Figure 13. Online Pharmacy
Figure 14. Global Anti-premature Ejaculation Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-premature Ejaculation Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Anti-premature Ejaculation Drug Sales (2020-2031) & (K Units)
Figure 17. Global Anti-premature Ejaculation Drug Average Price (US$/Unit) & (2020-2031)
Figure 18. Anti-premature Ejaculation Drug Report Years Considered
Figure 19. Anti-premature Ejaculation Drug Sales Share by Manufacturers in 2024
Figure 20. Global Anti-premature Ejaculation Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Anti-premature Ejaculation Drug Players: Market Share by Revenue in Anti-premature Ejaculation Drug in 2024
Figure 22. Anti-premature Ejaculation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Anti-premature Ejaculation Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Anti-premature Ejaculation Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Anti-premature Ejaculation Drug Revenue Market Share by Country (2020-2031)
Figure 26. United States Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Anti-premature Ejaculation Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Anti-premature Ejaculation Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Anti-premature Ejaculation Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Anti-premature Ejaculation Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Anti-premature Ejaculation Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Anti-premature Ejaculation Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Anti-premature Ejaculation Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Anti-premature Ejaculation Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Anti-premature Ejaculation Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-premature Ejaculation Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Anti-premature Ejaculation Drug by Type (2020-2031)
Figure 56. Global Anti-premature Ejaculation Drug Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Anti-premature Ejaculation Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Anti-premature Ejaculation Drug by Application (2020-2031)
Figure 59. Global Anti-premature Ejaculation Drug Price (US$/Unit) by Application (2020-2031)
Figure 60. Anti-premature Ejaculation Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
